Latest from Sidney Kimmel Cancer Center at Jefferson

Benjamin P. Levy, MD, discusses the identification of molecular drivers in non–small cell lung cancer.
 

Leonard G. Gomella, MD, discusses the growth of genetic testing in prostate cancer, how to determine who should undergo testing, and what the future holds in this space.

Veda N. Giri, MD, discusses the increasing need for genetic counseling among men at risk of developing prostate cancer. 
 

Leonard G. Gomella, MD, discusses the challenges of genetic testing in prostate cancer. 
 

Leonard G. Gomella, MD, FACS, discusses the role of genetic testing and emerging biomarkers in prostate cancer.

Leonard G. Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses the prevalence of genetic testing in prostate cancer.

Leonard G. Gomella, MD, underscores the need for genetic testing in prostate cancer, sheds light on important biomarkers in the space, and explains how these tests are helping oncologists facilitate a precision medicine approach.

The Sidney Kimmel Cancer Center – Jefferson Health recently welcomed Anjali Mishra, PhD, and Nitin Chakravarti, PhD, to a growing team of researchers focused on hematologic cancers.